Scopia Management, Inc., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 185,000 shares at $16.94 ($3.1M) on 2019-01-16, disclosed to the SEC on 2019-01-17.
Open-market sale of $3.1M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.60 | 1,700 | $28K | 0.9% |
| 2 | $16.94 | 91,650 | $1.6M | 49.5% |
| 3 | $16.94 | 91,650 | $1.6M | 49.5% |
| Total | $16.94 avg | 185,000 | $3.1M | 100% |
| Filing → |
| ITRI | SELL | 2019-04-16 | $5.9M | — | Filing → |
| ITRI | SELL | 2019-03-29 | $3.0M | — | Filing → |
| ITRI | SELL | 2019-03-25 | $5.8M | — | Filing → |